AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 62 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $75,097,000 | -25.1% | 4,621,325 | -33.1% | 4.50% | -39.7% |
| Q1 2020 | $100,255,000 | -25.3% | 6,909,374 | +4.3% | 7.46% | -8.9% |
| Q4 2019 | $134,236,000 | +881.5% | 6,625,671 | +158.7% | 8.19% | +505.5% |
| Q3 2019 | $13,677,000 | -50.8% | 2,561,269 | -39.3% | 1.35% | -31.2% |
| Q2 2019 | $27,784,000 | +1.2% | 4,222,558 | 0.0% | 1.97% | +13.4% |
| Q1 2019 | $27,447,000 | +40263.2% | 4,222,558 | +42125.6% | 1.73% | +34560.0% |
| Q4 2018 | $68,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |